Your browser doesn't support javascript.
loading
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions.
Zaratin, Paola; Vermersch, Patrick; Amato, Maria Pia; Brichetto, Giampaolo; Coetzee, Timothy; Cutter, Gary; Edan, Gilles; Giovannoni, Gavin; Gray, Emma; Hartung, Hans Peter; Hobart, Jeremy; Helme, Anne; Hyde, Robert; Khan, Usman; Leocani, Letizia; Mantovani, Lorenzo Giovanni; McBurney, Robert; Montalban, Xavier; Penner, Iris-Katharina; Uitdehaag, Bernard M J; Valentine, Pamela; Weiland, Helga; Bertorello, Deborah; Battaglia, Mario Alberto; Baneke, Peer; Comi, Giancarlo.
Afiliação
  • Zaratin P; Research Department, Italian Multiple Sclerosis Foundation, Via Operai 40, Genoa, Italy. Electronic address: paola.zaratin@aism.it.
  • Vermersch P; Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.
  • Amato MP; Department of NEUROFARBA, University of Florence, IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
  • Brichetto G; Research Department, Italian Multiple Sclerosis Foundation, Via Operai 40, Genoa, Italy.
  • Coetzee T; National Multiple Sclerosis Society, New York, United States of America.
  • Cutter G; Department of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, United States of America.
  • Edan G; Neurology Department, University Hospital of Rennes, Rennes, France.
  • Giovannoni G; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Gray E; Multiple Sclerosis Society, London, UK.
  • Hartung HP; Department of Neurology, UKD, Medical Faculty, Heinrich Heine Universität, Düsseldorf, Germany; Brain and Mind Center, University of Sydney, Australia; Department of Neurology, Medical University of Vienna, Austria; Department of Neurology, Palacky University Olomouc, Czech Republic.
  • Hobart J; Plymouth University Peninsula Schools of Medicine and Dentistry Devon, UK.
  • Helme A; Multiple Sclerosis International Federation, London, UK.
  • Hyde R; Biogen International GmbH, Switzerland.
  • Khan U; Institute for Healthcare Policy, KU Leuven, Belgium.
  • Leocani L; Vita-Salute San Raffaele University, Milan, Italy.
  • Mantovani LG; Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy; IRCCS Multimedica, Sesto San Giovanni, Italy.
  • McBurney R; Accelerated Cure Project, Waltham, MA, United States of America.
  • Montalban X; Hopital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Penner IK; Department of Neurology, Medical Faculty, Heinrich-Heine-University, Dusseldorf, Germany.
  • Uitdehaag BMJ; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherland.
  • Valentine P; Multiple Sclerosis Society of Canada, Toronto, Canada.
  • Weiland H; Multiple Sclerosis South Africa, Western Cape, South African.
  • Bertorello D; Research Department, Italian Multiple Sclerosis Foundation, Via Operai 40, Genoa, Italy.
  • Battaglia MA; Department of Life Science, University of Siena, Siena, Italy.
  • Baneke P; Multiple Sclerosis International Federation, London, UK.
  • Comi G; Vita-Salute San Raffaele University, Milan, Italy; Casa di Cura del Policlinico, Milan, Italy.
Mult Scler Relat Disord ; 61: 103757, 2022 May.
Article em En | MEDLINE | ID: mdl-35367873
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article